Cardinal Health, Inc. is a healthcare services and products firm based in Dublin, Ohio. It manages pharmaceutical and medical supplies distribution, enhancing patient care quality. With a market capitalization of $47.04 billion, it is considered a large-cap stock.

Shares of Cardinal Health hit a 52-week high of $214.93 on Nov. 26, up 31.2% in the past three months. The company’s stock has consistently outperformed the Nasdaq Composite index, gaining 62.9% over the past 52 weeks.

In its first-quarter fiscal 2026 results, Cardinal Health reported a 22% year-over-year revenue increase to $64.01 billion, surpassing analyst expectations. Non-GAAP EPS also rose 36% to $2.55, prompting a 15.4% stock increase. The company raised its fiscal 2026 non-GAAP EPS outlook to $9.65-$9.85.

Cardinal Health recently acquired urology MSO Solaris Health, adding 750 providers to its platform. Compared to Cencora, Inc., Cardinal Health has clearly outperformed, with a 62.9% stock gain over the past 52 weeks.

Read more at Yahoo Finance: Is Cardinal Health Stock Outperforming the Nasdaq?